Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.24.2
Fair Value of Financial Instruments (Tables)
 3 Months Ended
May 31, 2024
Fair Value Disclosures [Abstract]  
Financial assets and liabilities measured at estimated fair value on a recurring basis
The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis:
Fair Value Measurements Using
Quoted
Prices in
Active
Markets
(Level 1)		 Significant
Other
Observable
Inputs
(Level 2)		 Significant
Unobservable
Inputs
(Level 3)		 Total
(in millions)
May 31, 2024
Assets:
Foreign currency contracts $ —  $ 291.7  $ —  $ 291.7 
Commodity derivative contracts $ —  $ 16.9  $ —  $ 16.9 
Liabilities:
Foreign currency contracts $ —  $ 6.8  $ —  $ 6.8 
Commodity derivative contracts $ —  $ 23.6  $ —  $ 23.6 
February 29, 2024
Assets:
Foreign currency contracts $ —  $ 311.2  $ —  $ 311.2 
Commodity derivative contracts $ —  $ 6.2  $ —  $ 6.2 
Liabilities:
Foreign currency contracts $ —  $ 5.4  $ —  $ 5.4 
Commodity derivative contracts $ —  $ 36.0  $ —  $ 36.0 
Assets and liabilities measured at estimated fair value on a nonrecurring basis
The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented:
Fair Value Measurements Using
Quoted
Prices in
Active
Markets
(Level 1)		 Significant
Other
Observable
Inputs
(Level 2)		 Significant
Unobservable
Inputs
(Level 3)		 Total Losses
(in millions)
For the Three Months Ended May 31, 2023
Equity method investments $ 142.7  $ —  $ —  $ 123.5